• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压和动脉导管未闭对疑似肺发育不全早产儿的影响。

Impact of Pulmonary Hypertension and Patent Ductus Arteriosus in Preterm Infants with Presumed Pulmonary Hypoplasia.

作者信息

Kim Sol, Seo Yumi, Oh Moon-Yeon, Kim Min Soo, Yum Sook Kyung

机构信息

Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Department of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

出版信息

Biomedicines. 2025 Jul 15;13(7):1725. doi: 10.3390/biomedicines13071725.

DOI:10.3390/biomedicines13071725
PMID:40722795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12292432/
Abstract

: Pulmonary hypertension and hemodynamically significant PDA (hsPDA) involve seemingly opposite physiological features-decreased pulmonary blood flow and pulmonary overcirculation, respectively-but the literature demonstrates variable respiratory consequences in association with each of these morbidities. The aim of this study is to evaluate whether the two factors representing pulmonary circulation provide different contributions to respiratory outcomes in preterm infants with and without pulmonary hypoplasia. : The medical records of preterm very low birth weight (VLBW) infants admitted to our unit during the study period from January 2013 to December 2020 were retrospectively reviewed. Preterm VLBW infants were divided into groups according to the presence of presumed pulmonary hypoplasia (PPH). Multivariable logistic regression analysis was performed to assess the association of PPH and pulmonary hypertension or delayed PDA closure with in-hospital outcomes. : Postnatal age at final treatment for PDA was significantly later [median 33 vs. 19 days, = 0.025] in the PPH group. Multivariable analysis indicated that early pulmonary hypertension was significantly associated with neonatal death [aOR (95%CI) 11.575 (2.988-44.833) for no-PPH vs. 9.981 (1.334-74.647) for PPH]. Delayed PDA closure was associated with increased odds of adverse respiratory and composite outcomes [aOR (95%CI) 4.929 (1.613-15.055) and 3.320 (1.048-10.515), respectively] but decreased odds of neonatal death in the no-PPH group. However, Cox proportional hazards models did not demonstrate statistically significant associations for PPH, early pulmonary hypertension, or delayed PDA closure with mortality, likely due to time-varying effects and the absence of death events in the subgroup of infants with both PPH and delayed PDA closure. : PPH is associated with a higher prevalence of air leak syndrome and pulmonary hypertension. Delayed PDA closure exerts different effects on respiratory outcomes in preterm VLBW infants with and without PPH. Although early pulmonary hypertension appears to be a key circulatory factor contributing to neonatal death, its effect may vary over time. These findings underscore the importance of accounting for time-dependent effects when interpreting pulmonary circulatory risk factors in clinical practice.

摘要

肺动脉高压和血流动力学上具有显著意义的动脉导管未闭(hsPDA)分别涉及看似相反的生理特征——肺血流减少和肺循环过度,但文献表明,与这些疾病中的每一种相关的呼吸后果各不相同。本研究的目的是评估代表肺循环的两个因素对有无肺发育不全的早产儿呼吸结局的贡献是否不同。

回顾性分析了2013年1月至2020年12月研究期间入住我科的极低出生体重(VLBW)早产儿的病历。根据假定的肺发育不全(PPH)情况将VLBW早产儿分组。进行多变量逻辑回归分析,以评估PPH、肺动脉高压或动脉导管未闭延迟关闭与住院结局之间的关联。

PPH组动脉导管未闭最终治疗时的出生后年龄显著更晚[中位数33天对19天,P = 0.025]。多变量分析表明,早期肺动脉高压与新生儿死亡显著相关[无PPH组的调整后比值比(95%置信区间)为11.575(2.988 - 44.833),PPH组为9.981(1.334 - 74.647)]。动脉导管未闭延迟关闭与不良呼吸和综合结局的几率增加相关[调整后比值比(95%置信区间)分别为4.929(1.613 - 15.055)和3.320(1.048 - 10.515)],但在无PPH组中与新生儿死亡几率降低相关。然而,Cox比例风险模型未显示PPH、早期肺动脉高压或动脉导管未闭延迟关闭与死亡率之间存在统计学显著关联,可能是由于时变效应以及PPH和动脉导管未闭延迟关闭并存的婴儿亚组中无死亡事件。

PPH与空气泄漏综合征和肺动脉高压的较高患病率相关。动脉导管未闭延迟关闭对有无PPH的VLBW早产儿的呼吸结局有不同影响。虽然早期肺动脉高压似乎是导致新生儿死亡的关键循环因素,但其影响可能随时间变化。这些发现强调了在临床实践中解释肺循环危险因素时考虑时间依赖性效应的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f85/12292432/ed513ac66566/biomedicines-13-01725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f85/12292432/f04b5f07ecec/biomedicines-13-01725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f85/12292432/ed513ac66566/biomedicines-13-01725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f85/12292432/f04b5f07ecec/biomedicines-13-01725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f85/12292432/ed513ac66566/biomedicines-13-01725-g002.jpg

相似文献

1
Impact of Pulmonary Hypertension and Patent Ductus Arteriosus in Preterm Infants with Presumed Pulmonary Hypoplasia.肺动脉高压和动脉导管未闭对疑似肺发育不全早产儿的影响。
Biomedicines. 2025 Jul 15;13(7):1725. doi: 10.3390/biomedicines13071725.
2
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003481. doi: 10.1002/14651858.CD003481.pub3.
3
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.对乙酰氨基酚(醋氨酚)用于早产儿或低出生体重儿动脉导管未闭。
Cochrane Database Syst Rev. 2018 Apr 6;4(4):CD010061. doi: 10.1002/14651858.CD010061.pub3.
4
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.早产儿血流动力学显著的动脉导管未闭的早期治疗与观察性管理
Cochrane Database Syst Rev. 2025 Jun 23;6(6):CD013278. doi: 10.1002/14651858.CD013278.pub3.
5
Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产儿和/或低出生体重儿的动脉导管未闭。
Cochrane Database Syst Rev. 2003(2):CD003481. doi: 10.1002/14651858.CD003481.
6
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003481. doi: 10.1002/14651858.CD003481.pub2.
7
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.对早产儿或低出生体重儿的动脉导管未闭(patent ductus arteriosus),使用扑热息痛(acetaminophen,对乙酰氨基酚)。
Cochrane Database Syst Rev. 2022 Dec 15;12:CD010061. doi: 10.1002/14651858.CD010061.pub5.
8
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.环氧化酶抑制剂用于早产儿有症状动脉导管未闭的手术治疗与药物治疗对比
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003951. doi: 10.1002/14651858.CD003951.pub2.
9
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.早治疗与期待治疗对早产儿有血流动力学意义的动脉导管未闭的效果比较。
Cochrane Database Syst Rev. 2020 Dec 10;12(12):CD013278. doi: 10.1002/14651858.CD013278.pub2.
10
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.布洛芬用于治疗早产或低出生体重(或两者兼具)婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2018 Sep 28;9(9):CD003481. doi: 10.1002/14651858.CD003481.pub7.

本文引用的文献

1
Comparison of mortality and survival without major morbidities of very preterm infants with very low birth weight from Japan and Brazil.比较日本和巴西极低出生体重早产儿无重大合并症的死亡率和存活率。
Rev Paul Pediatr. 2022 Sep 9;41:e2021389. doi: 10.1590/1984-0462/2023/41/2021389. eCollection 2022.
2
Clinical Significance of Early Pulmonary Hypertension in Preterm Infants.早产儿早期肺动脉高压的临床意义。
J Pediatr. 2022 Dec;251:74-81.e3. doi: 10.1016/j.jpeds.2022.07.039. Epub 2022 Aug 4.
3
Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
动脉导管未闭分流大小和持续时间对中国早产儿死亡或严重呼吸系统并发症风险的影响。
Eur J Pediatr. 2022 Aug;181(8):3131-3140. doi: 10.1007/s00431-022-04549-x. Epub 2022 Jul 15.
4
Pneumothorax prevalence and mortality per gestational age in the newborn.新生儿气胸的患病率和病死率按胎龄分布。
Pediatr Pulmonol. 2021 Aug;56(8):2583-2588. doi: 10.1002/ppul.25454. Epub 2021 May 18.
5
Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants.动脉导管未闭治疗策略的变化与早产儿呼吸系统结局的关系
J Pediatr. 2021 Aug;235:58-62. doi: 10.1016/j.jpeds.2021.04.030. Epub 2021 Apr 21.
6
Neonatal Outcomes according to the Latent Period from Membrane Rupture to Delivery among Extremely Preterm Infants Exposed to Preterm Premature Rupture of Membrane: a Nationwide Cohort Study.极早产儿胎膜早破潜伏期与分娩间隔时间对新生儿结局的影响:一项全国性队列研究。
J Korean Med Sci. 2021 Apr 12;36(14):e93. doi: 10.3346/jkms.2021.36.e93.
7
Patent Ductus Arteriosus of the Preterm Infant.早产儿动脉导管未闭。
Pediatrics. 2020 Nov;146(5). doi: 10.1542/peds.2020-1209.
8
Hemodynamic and clinical consequences of early versus delayed closure of patent ductus arteriosus in extremely low birth weight infants.极早产儿动脉导管未闭的早期与延迟关闭对血流动力学和临床的影响。
J Perinatol. 2021 Jan;41(1):100-108. doi: 10.1038/s41372-020-00772-2. Epub 2020 Aug 13.
9
Neonatal outcome comparisons between preterm infants with or without early pulmonary hypertension following prolonged preterm premature rupture of membranes before 25 gestational weeks in Korean Neonatal Network.韩国新生儿网络中孕25周前胎膜早破时间延长的早产婴儿有无早期肺动脉高压的新生儿结局比较
J Matern Fetal Neonatal Med. 2022 Apr;35(7):1286-1294. doi: 10.1080/14767058.2020.1749590. Epub 2020 May 6.
10
Nitric Oxide in Pulmonary Hypoplasia: Results from the European iNO Registry.肺发育不全中的一氧化氮:来自欧洲 iNO 注册研究的结果。
Neonatology. 2019;116(4):341-346. doi: 10.1159/000501800. Epub 2019 Oct 3.